No headlines found.
ACCESS Newswire (Wed, 17-Dec 7:40 AM ET)
Wellgistics Health Announces Launch of Diabetes Drug Brenzavvy(R) to Wellgistics Pharmacy Network
ACCESS Newswire (Mon, 8-Dec 7:40 AM ET)
ACCESS Newswire (Thu, 4-Dec 6:00 AM ET)
AB Digital Inc (Wed, 26-Nov 2:31 PM ET)
ACCESS Newswire (Wed, 26-Nov 7:45 AM ET)
Globe Newswire (Tue, 25-Nov 4:07 PM ET)
Wellgistics Health Reports Third Quarter 2025 Financial Results and Provides Business Update
ACCESS Newswire (Thu, 20-Nov 6:00 AM ET)
ACCESS Newswire (Mon, 17-Nov 6:00 AM ET)
ACCESS Newswire (Fri, 14-Nov 9:00 AM ET)
ACCESS Newswire (Wed, 12-Nov 7:40 AM ET)
Wellgistics Health Inc is a healthcare technology and pharmaceutical logistics company. It simplifies the logistics of prescription fulfillment from the manufacturer and provider to the patient. It is focused on improving the lives of patients while delivering unique solutions for pharmacies, providers, pharmaceutical manufacturers, and payors.
Wellgistics Health trades on the NASDAQ stock market under the symbol WGRX.
As of December 30, 2025, WGRX stock price declined to $0.37 with 435,406 million shares trading.
WGRX has a beta of -0.08, meaning it tends to be less sensitive to market movements. WGRX has a correlation of 0.00 to the broad based SPY ETF.
WGRX has a market cap of $37.85 million. This is considered a Sub-Micro Cap stock.
The top ETF exchange traded funds that WGRX belongs to (by Net Assets): VXF.
WGRX support price is $.36 and resistance is $.40 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that WGRX shares will trade within this expected range on the day.
